Payments to Acquire Property, Plant, and Equipment of Trevi Therapeutics, Inc. from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Trevi Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • Trevi Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2023 was $57,000.
  • Trevi Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $12,000, a 66% decline from 2024.
  • Trevi Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $35,000, a 74% decline from 2023.
  • Trevi Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $137,000, a 14% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Trevi Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $12,000 -$23,000 -66% 01 Jan 2025 31 Dec 2025 10-K 17 Mar 2026 2025 FY
2024 $35,000 -$102,000 -74% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2026 2025 FY
2023 $137,000 -$22,000 -14% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 $159,000 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024 2023 FY
2020 $32,000 +$23,000 +256% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2019 $9,000 -$149,000 -94% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
2018 $158,000 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020 2019 FY

Trevi Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $57,000 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2019 $9,000 -$48,000 -84% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $57,000 01 Jan 2018 31 Mar 2018 10-Q 14 Jun 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.